Global Sexually Transmitted Disease (STD) Testing Market 2019-2023
SKU ID : TNV-14498971 | Publishing Date : 23-Jul-2019 | No. of pages : 129
Detailed TOC of Global Sexually Transmitted Disease (STD) Testing Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
•2.1 Preface
•2.2 Preface
•2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
•Market ecosystem
•Market characteristics
•Market segmentation analysis
PART 04: MARKET SIZING
•Market definition
•Market sizing 2018
•Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
•Bargaining power of buyers
•Bargaining power of suppliers
•Threat of new entrants
•Threat of substitutes
•Threat of rivalry
•Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
•Market segmentation by product
•Comparison by product
•Laboratory testing devices - Market size and forecast 2018-2023
•POC testing devices - Market size and forecast 2018-2023
•Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
•Geographic segmentation
•Geographic comparison
•North America - Market size and forecast 2018-2023
•Europe - Market size and forecast 2018-2023
•Asia - Market size and forecast 2018-2023
•ROW - Market size and forecast 2018-2023
•Key leading countries
•Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
•Market drivers
•Market challenges
PART 11: MARKET TRENDS
•Increasing involvement of various organizations to create awareness
about STDs
•Advances that enable the rapid diagnosis of STDs
•Approval of drugs and strong drug pipeline
PART 12: VENDOR LANDSCAPE
•Overview
•Landscape disruption
PART 13: VENDOR ANALYSIS
•Vendors covered
•Vendor classification
•Market positioning of vendors
•Abbott Laboratories
•bioMérieux SA
•Bio-Rad Laboratories Inc.
•Danaher Corp.
•F. Hoffmann-La Roche Ltd.
PART 14: APPENDIX
•Research methodology
•List of abbreviations
•Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Product overview
Exhibit 02: Global healthcare market
Exhibit 03: Segments of global healthcare market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ billions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Laboratory testing devices - Market size and forecast 2018-2023 ($ billions)
Exhibit 21: Laboratory testing devices - Year-over-year growth 2019-2023 (%)
Exhibit 22: POC testing devices - Market size and forecast 2018-2023 ($ billions)
Exhibit 23: POC testing devices - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2018-2023 ($ billions)
Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
Exhibit 30: Europe - Market size and forecast 2018-2023 ($ billions)
Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 32: Asia - Market size and forecast 2018-2023 ($ billions)
Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 34: ROW - Market size and forecast 2018-2023 ($ billions)
Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Abbott Laboratories - Vendor overview
Exhibit 45: Abbott Laboratories - Business segments
Exhibit 46: Abbott Laboratories - Organizational developments
Exhibit 47: Abbott Laboratories - Geographic focus
Exhibit 48: Abbott Laboratories - Segment focus
Exhibit 49: Abbott Laboratories - Key offerings
Exhibit 50: bioMérieux SA - Vendor overview
Exhibit 51: bioMérieux SA - Product segments
Exhibit 52: bioMérieux SA - Organizational developments
Exhibit 53: bioMérieux SA - Geographic focus
Exhibit 54: bioMérieux SA - Key offerings
Exhibit 55: Bio-Rad Laboratories Inc. - Vendor overview
Exhibit 56: Bio-Rad Laboratories Inc. - Business segments
Exhibit 57: Bio-Rad Laboratories Inc. - Organizational developments
Exhibit 58: Bio-Rad Laboratories Inc. - Geographic focus
Exhibit 59: Bio-Rad Laboratories Inc. - Segment focus
Exhibit 60: Bio-Rad Laboratories Inc. - Key offerings
Exhibit 61: Danaher Corp. - Vendor overview
Exhibit 62: Danaher Corp. - Product segments
Exhibit 63: Danaher Corp. - Organizational developments
Exhibit 64: Danaher Corp. - Geographic focus
Exhibit 65: Danaher Corp. - Segment focus
Exhibit 66: Danaher Corp. - Key offerings
Exhibit 67: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 68: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 69: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 70: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 71: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 72: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: Definition of market positioning of vendors